Document and Entity Information
| Document and Entity Information | Jan. 22, 2024 |
| Cover [Abstract] | |
| Entity Registrant Name | Dianthus Therapeutics, Inc. /DE/ |
| Security Exchange Name | NASDAQ |
| Amendment Flag | false |
| Entity Central Index Key | 0001690585 |
| Document Type | 8-K |
| Document Period End Date | Jan. 22, 2024 |
| Entity Incorporation State Country Code | DE |
| Entity File Number | 001-38541 |
| Entity Tax Identification Number | 81-0724163 |
| Entity Address, Address Line One | 7 Times Square |
| Entity Address, Address Line Two | 43rd Floor |
| Entity Address, City or Town | New York |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 10036 |
| City Area Code | 929 |
| Local Phone Number | 999-4055 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Security 12b Title | Common Stock, $0.001 Par Value |
| Trading Symbol | DNTH |
| Entity Emerging Growth Company | false |